Two Chinese DRAM ventures launched in 2016 with government backing. A decade later, ChangXin Memory Technologies (CXMT) and Fujian Jinhua (JHICC) offer sharply different stories about what it takes to build a memory chip business under U.S. technology restrictions.
Aaron Zhou and Diane Ding examine four forces behind that divergence: patient capital, intellectual property, export controls, and the memory industry’s pricing cycle. They discuss Hefei’s approach to financing capital-intensive manufacturing, CXMT’s use of acquired and licensed IP, and why the timing of restrictions mattered. The conversation also explores how the company endured a downturn before rising AI demand helped change its prospects.
Hosts
* Aaron Zhou, investor, co-host, co-editor of Baiguan.news
* Diane Ding, co-host and co-founder of ShengFM
Disclaimer: The information in this episode is provided for informational purposes only and does not constitute legal or financial advice. All commentary reflects the personal views of the guests, based on publicly available information and first-hand operational experience.
